Education
About Us
Working with TipRanks
Follow Us
Arnold Pinkston Insider Profile
4 Followers
Arnold Pinkston, EVP & GC at Allergan, holds 308.00 shares in Bio-Rad Laboratories (Ticker: BIO), holds 24.16K shares in Corelogic (Ticker: CLGX), holds 0.00 shares in Janus Capital (Ticker: JNS).
Arnold Pinkston Allergan (AGN)EVP & GC
Allergan (AGN)
EVP & GC
Not Ranked
Arnold Pinkston has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Arnold Pinkston holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Arnold Pinkston
Arnold Pinkston's Trading History
Allergan
Mar 19, 2015
―
Uninformative Sell
―
$0.00
Janus Capital
Jun 01, 2017
―
Uninformative Sell
―
$0.00
Bio-Rad Laboratories
Apr 24, 2025
Director
Uninformative Buy
75.45K
$89.44K
Corelogic
Mar 06, 2019
―
Uninformative Buy
―
$1.93M
List of latest transactions for each holding click on a transaction to see Arnold Pinkston's performance on stock
You May Also Like
Arnold Pinkston insider profile FAQ
What is the percentage of profitable transactions made by Arnold Pinkston?
The percentage of profitable transactions made by Arnold Pinkston is ―.
What is the average return per transaction made by Arnold Pinkston?
The average return per transaction made by Arnold Pinkston is ―.
What stocks does Arnold Pinkston hold?
Arnold Pinkston holds: AGN, JNS, BIO, CLGX stocks.
What was Arnold Pinkston’s latest transaction?
Arnold Pinkston latest transaction was an Uninformative Buy of $75.45K.
What was Arnold Pinkston's most profitable transaction?
Arnold Pinkston’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Arnold Pinkston's role in Allergan?
Arnold Pinkston's role in Allergan is EVP & GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.